Pharmaceutical industry criticizes the drug pricing plan Trump says he’ll sign
By AMANDA SEITZ and WILL WEISSERT, Associated Press WASHINGTON (AP) — President Donald Trump’s plan to change the pricing model for some medications is already facing fierce criticism from the pharmaceutical industry before he’s even signed the executive order set … Continued